Found 210 with Last Name = 'garofalo' and Initial = 'b' 
Affinity DataIC50: 8nMAssay Description:Inhibition of Staphylococcus aureus DNA gyraseMore data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 10nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 10nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 10nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of Staphylococcus aureus DNA gyraseMore data for this Ligand-Target Pair
3D Structure (crystal)TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 20nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of Escherichia coli DNA gyrase assessed as reduction in enzyme-mediated supercoiling of relaxed plasmid by fluorescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of Staphylococcus aureus ATCC 29213 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium b...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of Staphylococcus aureus ATCC 29213 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium b...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 20nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Inhibition of Staphylococcus aureus ATCC 29213 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated fo...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium bromid...More data for this Ligand-Target Pair
Affinity DataIC50: 47nMAssay Description:Inhibition of Staphylococcus aureus DNA gyraseMore data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Inhibition of Staphylococcus aureus ATCC 29213 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated fo...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated for 30 ...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Inhibition of Staphylococcus aureus ATCC 29213 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium b...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of Escherichia coli DNA gyraseMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated for 30 ...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Inhibition of Staphylococcus aureus ATCC 29213 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated fo...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium bromid...More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated for 30 ...More data for this Ligand-Target Pair
Affinity DataIC50: 125nMAssay Description:Inhibition of Escherichia coli DNA gyraseMore data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 130nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 140nMAssay Description:Inhibition of Escherichia coli DNA gyraseMore data for this Ligand-Target Pair
Affinity DataIC50: 150nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium bromid...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 170nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated for 30 ...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 210nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 210nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 230nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 260nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibition of Staphylococcus aureus ATCC 29213 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated fo...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 300nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibition of Staphylococcus aureus ATCC 29213 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated fo...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 310nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 310nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 310nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 310nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 320nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 330nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 350nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 350nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 360nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 360nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA topoisomerase 4 subunit ParC assessed as reduction in decatenation of kinetoplast DNA incubated for 30 ...More data for this Ligand-Target Pair
Affinity DataIC50: 400nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium bromid...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 400nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 400nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 450nMT: 2°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
Affinity DataIC50: 500nMAssay Description:Inhibition of Escherichia coli ATCC 25922 DNA gyrase A assessed as reduction in enzyme-mediated supercoiling of relaxed pBR322 DNA by ethidium bromid...More data for this Ligand-Target Pair
